Association between C-reactive protein level and peripheral arterial disease among US adults without cardiovascular disease, diabetes, or hypertension

American Heart Journal

Volumn 154, Issue 3, 2007, Pages 495-501

  Shankar, Anoop ^a   Li, Jialiang ^b   Nieto, F Javier ^c   Klein, Barbara E K ^c   Klein, Ronald ^c  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTERY DISEASE; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONFIDENCE INTERVAL; DIABETES MELLITUS; EDUCATION; FEMALE; HUMAN; HUMAN EXPERIMENT; HYPERTENSION; INFLAMMATION; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK FACTOR; SMOKING; UNITED STATES; WAIST CIRCUMFERENCE;

C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; UNITED STATES;

EID: 34547956482     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2007.04.060     Document Type: Article

References (34)

1. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
2. Ridker P.M., Stampfer M.J., and Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 285 (2001) 2481-2485
3. Ridker P.M., Cushman M., Stampfer M.J., et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336 (1997) 973-979
4. Wilson P.W. CDC/AHA workshop on markers of inflammation and cardiovascular disease: application to clinical and public health practice: ability of inflammatory markers to predict disease in asymptomatic patients: a background paper. Circulation 110 (2004) e568-e571
5. Lucas A.R., Korol R., and Pepine C.J. Inflammation in atherosclerosis: some thoughts about acute coronary syndromes. Circulation 113 (2006) e728-e732
6. Albert M.A., and Ridker P.M. C-reactive protein as a risk predictor: do race/ethnicity and gender make a difference?. Circulation 114 (2006) e67-e74
7. Danesh J., Wheeler J.G., Hirschfield G.M., et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350 (2004) 1387-1397
8. Koenig W., Lowel H., Baumert J., et al. C-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern Germany. Circulation 109 (2004) 1349-1353
9. Aboyans V., Criqui M.H., Denenberg J.O., et al. Risk factors for progression of peripheral arterial disease in large and small vessels. Circulation 113 (2006) 2623-2629
10. Wildman R.P., Muntner P., Chen J., et al. Relation of inflammation to peripheral arterial disease in the national health and nutrition examination survey, 1999-2002. Am J Cardiol 96 (2005) 1579-1583
11. Vu J.D., Vu J.B., Pio J.R., et al. Impact of C-reactive protein on the likelihood of peripheral arterial disease in United States adults with the metabolic syndrome, diabetes mellitus, and preexisting cardiovascular disease. Am J Cardiol 96 (2005) 655-658
12. Tzoulaki I., Murray G.D., Lee A.J., et al. C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh Artery Study. Circulation 112 (2005) 976-983
13. Ridker P.M., Cushman M., Stampfer M.J., et al. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 97 (1998) 425-428
14. Thorand B., Lowel H., Schneider A., et al. C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study, 1984-1998. Arch Intern Med 163 (2003) 93-99
15. Sesso H.D., Buring J.E., Rifai N., et al. C-reactive protein and the risk of developing hypertension. JAMA 290 (2003) 2945-2951
16. Criqui M.H., Denenberg J.O., Langer R.D., et al. The epidemiology of peripheral arterial disease: importance of identifying the population at risk. Vasc Med 2 (1997) 221-226
17. Selvin E., and Erlinger T.P. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 110 (2004) 738-743
18. Greenland P., Knoll M.D., Stamler J., et al. Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA 290 (2003) 891-897
19. Khera A., de Lemos J.A., Peshock R.M., et al. Relationship between C-reactive protein and subclinical atherosclerosis: the Dallas Heart Study. Circulation 113 (2006) 38-43
20. Bowden D.W., Lange L.A., Langefeld C.D., et al. The relationship between C-reactive protein and subclinical cardiovascular disease in the Diabetes Heart Study (DHS). Am Heart J 150 (2005) 1032-1038
21. Folsom A.R., Pankow J.S., Tracy R.P., et al. Association of C-reactive protein with markers of prevalent atherosclerotic disease. Am J Cardiol 88 (2001) 112-117
22. McDermott M.M., Green D., Greenland P., et al. Relation of levels of hemostatic factors and inflammatory markers to the ankle brachial index. Am J Cardiol 92 (2003) 194-199
23. National Center for Health Statistics. NHANES 1999-2002 addendum to the NHANES III analytic guidelines [article online]. Available online from: (2006). www.cdc.gov/nchs/data/nhanes/guidelines1.pdf [Accessed October 2, 2006]
24. Newman A.B., Siscovick D.S., Manolio T.A., et al. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group. Circulation 88 (1993) 837-845
25. Gregg E.W., Sorlie P., Paulose-Ram R., et al. Prevalence of lower-extremity disease in the US adult population ≥40 years of age with and without diabetes: 1999-2000 national health and nutrition examination survey. Diabetes Care 27 (2004) 1591-1597
26. American Diabetes Association. Peripheral arterial disease in people with diabetes (consensus statement). Diabetes Care 26 (2003) 3333-3341
27. National Center for Health Statistics. Lab methods NHANES 1999-2002. Available at: (2006). www.cdc.gov/nchs/data/nhanes/nhanes_01_02/l11_b_doc.pdf [Accessed October 2, 2006]
28. Hastie T., and Tibshirani R. Generalized additive models. 1st ed. (1990), Chapman and Hall, London
29. Figueiras A., and Cadarso-Suarez C. Application of nonparametric models for calculating odds ratios and their confidence intervals for continuous exposures. Am J Epidemiol 154 (2001) 264-275
30. Kawamoto R., Tomita H., Oka Y., et al. Association between uric acid and carotid atherosclerosis in elderly persons. Intern Med 44 (2005) 787-793
31. Vita J.A., Keaney Jr. J.F., Larson M.G., et al. Brachial artery vasodilator function and systemic inflammation in the Framingham Offspring Study. Circulation 110 (2004) 3604-3609
32. Jarvisalo M.J., Harmoinen A., Hakanen M., et al. Elevated serum C-reactive protein levels and early arterial changes in healthy children. Arterioscler Thromb Vasc Biol 22 (2002) 1323-1328
33. Folsom A.R., Chambless L.E., Ballantyne C.M., et al. An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the atherosclerosis risk in communities study. Arch Intern Med 166 (2006) 1368-1373
34. Grundy S.M., Gostino Sr. R.B., Mosca L., et al. Cardiovascular risk assessment based on US cohort studies: findings from a National Heart, Lung, and Blood institute workshop. Circulation 104 (2001) 491-496